Therapeutic effects of electroacupuncture at ST36 acupoint on sodium-taurocholate-induced severe acute pancreatitis.
- Author:
Qi-ming XUE
1
;
Ning LI
;
Ping XUE
;
Cheng-wei WANG
;
Qian WEN
Author Information
- Publication Type:Journal Article
- MeSH: Acetylcholine; metabolism; Acute Disease; Animals; Electroacupuncture; Enzyme-Linked Immunosorbent Assay; Interleukin-6; metabolism; Male; Pancreatitis; chemically induced; therapy; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Taurocholic Acid; toxicity; Tumor Necrosis Factor-alpha; metabolism
- From: Chinese journal of integrative medicine 2014;20(9):695-700
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo explore the protective effects and mechanisms of electroacupuncture (EA) at Zusanli (ST36) acupoint in rats with severe acute pancreatitis (SAP).
METHODSSixty-six male Sprague-Dawley rats were randomly assigned to three groups of 22 each: a SAP model group (SAP group), a shamoperated group (sham group) and a EA at ST36 acupoint group (EA group). A rat model of SAP was induced by pancreatic duct injection with 3.5% sodium taurocholate. EA was performed at ST36 acupoint for 30 min after induction of SAP and 30 min before sacrificed. The rats were killed at 3 h (n=7), 6 h (n=7) and 12 h (n=8) after operation, and blood samples were taken for the measurement of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and acetylcholine (Ach) by enzyme-linked immunosorbnent assay. The pathological changes of pancreatic tissue, volume of ascites and pancreatic weight/body weight ratio were measured.
RESULTSThe serum concentrations of TNF-α and IL-6 in the EA group were significantly lower than in the SAP group at 3, 6 and 12 h after the operation (p<0.05). Serum Ach in the EA group was significantly higher than in the SAP group at various time points after operation (p<0.05). The other parameters were clearly improved after treatment with EA.
CONCLUSIONEA at ST36 acupoint might have a therapeutic effect in rats with SAP through activating the cholinergic anti-inflammatory pathway.